Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2219 Target Snapshot

Tyrosine-protein phosphatase non-receptor type 7 · SINGLE PROTEIN · Homo sapiens

741Compounds
71Assays
2Approved Drugs
833.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P35236. Use UniProt P35236 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P35236 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Tyrosine-protein phosphatase non-receptor type 7 as ChEMBL target CHEMBL2219, mapped to UniProt P35236. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Tyrosine-protein phosphatase non-receptor type 7
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2219
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P35236
Tyrosine-protein phosphatase non-receptor type 7
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Tyrosine-protein phosphatase non-receptor type 7 is the right protein anchor across sources, using UniProt P35236 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTyrosine-protein phosphatase non-receptor type 7
UniProt AccessionP35236
Component TypeProtein
Sequence Length360 aa

Tyrosine-protein phosphatase non-receptor type 7

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Tyrosine-protein phosphatase non-receptor type 7, mapped to UniProt P35236. Sequence length is 360 aa.

Mapped IDP35236
Review nameTyrosine-protein phosphatase non-receptor type 7
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

IC50831.0
KI2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1605172 7.84 IC50 14.4 Preclinical
CHEMBL1322542 7.6 IC50 25.0 Preclinical
CHEMBL1408579 7.46 IC50 34.5 Preclinical
CHEMBL1304193 7.23 IC50 58.6 Preclinical
CHEMBL1460470 7.18 IC50 66.0 Preclinical
CHEMBL1608642 7.07 IC50 84.6 Preclinical
CHEMBL1360024 7.0 IC50 100.0 Preclinical
CHEMBL1445488 6.98 IC50 105.0 Preclinical
CHEMBL1505246 6.97 IC50 108.0 Preclinical
CHEMBL454668 6.9 IC50 125.0 Preclinical
Distribution

pChEMBL Value Distribution

106
5.0
107
5.5
72
6.0
23
6.5
5
7.0
2
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

CEPHALOTHIN SODIUM
CHEMBL1632
Approved 1974
Assay Landscape

Assay Landscape

71
Total Assays
302
Tested Compounds
3
Assay Types
Binding — 62 assays, 60 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 34 37 5.2
cell-based format 15 2 4.2
assay format 13 21 5.3
Functional — 8 assays, 302 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 8 302 5.5
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine